Ad
related to: dxc 500 au chemistry analyzer
Search results
Results from the WOW.Com Content Network
Julie Sawyer Montgomery, President Diagnostics, Suzanne Foster, President Life Sciences: Products: Biomek platforms, Synchron/AU analyzers, IRIS Immunochemistry system, VERIS, DxI immunoassay instruments, DxC chemistry instruments, DxH hematology instruments, Hemoccult, CEQ 2000 DNA Analysis System, Flow cytometers, Ultracentrifuge, Laboratory centrifuge
According to the report, the automatic immunoassay analyzer market was valued at $12.3 billion in 2023, and is estimated to reach $51.4 billion by 2033, growing at a ...
The AutoAnalyzer is an early example of an automated chemistry analyzer using a special flow technique named "continuous flow analysis (CFA)", invented in 1957 by Leonard Skeggs, PhD and first made by the Technicon Corporation. The first applications were for clinical (medical) analysis.
The D-500 Amino Acid Analyzer was designed and built by Durrum Instruments in the late 1960s. It was used by many prestigious universities and research facilities to test for presence and quantity of amino acids in biological samples.
The new firm became the world's largest company devoted to diagnostics, with sales of over $500 million. The "Dade" part of the name is a legacy of the Dade Reagents Company , founded by Dr. John Elliott near the end of the 1940s to provide consistent, high quality typing and testing of blood.
An immunoassay (IA) is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody (usually) or an antigen (sometimes).
His Robot Chemist "was the first commercially available discrete analyzer, and probably the first to produce results with a digital print-out." [ 1 ] Automatic discrete analysis instrumentation revolutionized the field of clinical chemistry, and, eventually, the practice of medicine, as well.
In May 2019, Salvino joined the board of directors of DXC Technology, and in September of that same year, he became CEO of the company. [13] In 2020, Salvino oversaw a deal to sell DXC's state and local health and human services business to Veritas Capital [14] for $5 billion. [15] In 2021, Salvino rejected an offer from French IT firm Atos to ...
Ad
related to: dxc 500 au chemistry analyzer